Democrats Launch Bipartisan Push to Halt Medicare AI Pilot Amidst Concerns of Delayed Senior Care

Senate and House Democrats have initiated a significant legislative effort to overturn a controversial Medicare pilot program that utilizes artificial intelligence (AI) to determine the approval or denial of patient care. The move, spearheaded by resolutions introduced on Wednesday, aims to halt the "Wasteful and Inappropriate Service Reduction" (WISeR) program, which has drawn sharp criticism and allegations of significantly delaying necessary medical treatment for seniors in at least six states where it is currently being implemented. This legislative challenge follows a critical ruling from the Government Accountability Office (GAO) last week, which determined that the WISeR program, by its nature, requires congressional approval and should have been submitted to lawmakers before its January rollout.

The latest push to dismantle the AI-driven prior authorization experiment underscores a growing bipartisan concern over the increasing integration of automated systems in healthcare decision-making, particularly when it impacts vulnerable populations. The Congressional Review Act (CRA) resolutions, introduced in both chambers of Congress, represent a formal mechanism to challenge federal agency rules and policies.

H2: The Genesis of the WISeR Program and Congressional Opposition

The WISeR program, launched by the Centers for Medicare and Medicaid Services (CMS) Innovation Center, was designed to identify and reduce potential fraud, waste, and abuse within Medicare by scrutinizing specific supplies and procedures. According to CMS, the program excludes services such as inpatient-only procedures, emergency services, and those where delay could pose substantial risks to patients. Under this pilot, healthcare providers are required to submit requests for these targeted services to designated WISeR contractors. These contractors then employ technologies, including AI, to review and either approve or deny the requests.

However, the operational structure of WISeR has raised significant red flags among lawmakers and healthcare advocates. A central point of contention is the payment model for these WISeR contractors. While the exact formula remains undisclosed by CMS, reports indicate that it incorporates the volume of denied procedures. This payment structure has led external experts to voice concerns that the program inadvertently incentivizes the denial of care, rather than the judicious review of medical necessity.

This potential conflict of interest was highlighted by Senator Ron Wyden (D-Ore.), ranking member of the Senate Finance Committee, who unequivocally stated, "Americans are sick and tired of abusive prior authorization tactics putting needed health care out of reach. The last thing seniors need is even more AI denying the care they need." Wyden is a primary sponsor of the Senate resolution, joined by a coalition of 20 Senate Democrats, including Majority Leader Patty Murray (D-Wash.), Senator Maria Cantwell (D-Wash.), Senator Richard Blumenthal (D-Conn.), and Senator Kirsten Gillibrand (D-N.Y.). Their collective action signifies a broad resistance to the program’s expansion beyond its current deployment in Arizona, New Jersey, Oklahoma, Ohio, Texas, and Washington.

In parallel, Representatives Suzan DelBene (D-Wash.) and Greg Landsman (D-Ohio) introduced a companion resolution in the House of Representatives. This is not the first time these lawmakers have sounded the alarm on the WISeR program. Representative DelBene previously introduced legislation to halt the Medicare experiment in the previous year, a move that was mirrored by similar legislative efforts in the Senate.

"WISeR is a dangerous program that is denying care to Medicare patients so companies can profit," Representative DelBene stated in a press release. "This program implements the same flawed prior authorization scheme from Medicare Advantage into traditional Medicare. If scaled up, it would be a back door to privatizing Medicare. It is causing needless delays, worsening conditions, and costing us more in the long run. Congress needs to step up and put an end to WISeR."

H3: The GAO Ruling: A Catalyst for Congressional Action

The timing of the Democrats’ legislative push is directly linked to a significant ruling issued by the Government Accountability Office (GAO) just last week. The GAO, a non-partisan federal agency that audits federal spending, determined that the WISeR program is indeed subject to congressional review and should have been formally submitted to Congress for approval before its implementation in January. This finding lends substantial weight to the Democrats’ argument that the program bypassed necessary legislative oversight.

The GAO’s determination provides a crucial legal and procedural basis for the CRA resolutions. By invoking the CRA, lawmakers are seeking to force a vote on their resolutions, aiming to overturn the CMS policy. The Congressional Review Act, enacted in 1996, provides Congress with a mechanism to review and potentially disapprove new rules issued by federal agencies. While the CRA has been used to challenge numerous agency rules, successfully overturning them is a rare occurrence. Historically, the most notable instances of CRA success involved the overturning of dozens of rules from the final months of the Obama administration at the commencement of the Trump administration.

H3: Evidence of Harm: Delayed Care and Worsening Conditions

The concerns voiced by lawmakers are not merely theoretical. Reports have emerged detailing the tangible negative impacts of the WISeR program on senior patients. In April, Senator Maria Cantwell highlighted instances of seniors in Washington state experiencing significant delays in accessing necessary medical care due to the program. During a congressional hearing at the time, she characterized the AI employed by CMS as a "denial device," underscoring her belief that the technology is being used to obstruct care rather than facilitate it.

These anecdotal accounts are consistent with the broader concerns raised by healthcare professionals and patient advocates. The potential for AI to misinterpret complex medical needs or to apply rigid rules that do not account for individual patient circumstances is a recurring theme in discussions about automated healthcare systems. The delay in care, even for a limited period, can have profound consequences for seniors, potentially leading to the exacerbation of existing health conditions, increased pain, and the need for more intensive and costly interventions down the line. The "costing us more in the long run" sentiment expressed by Representative DelBene points to a potential increase in overall healthcare expenditures as preventable conditions worsen.

H3: CMS Response and Ongoing Scrutiny

In response to the mounting criticism and the GAO ruling, a CMS spokesperson stated that WISeR "remains an active Innovation Center model, and CMS will continue to review the opinion and assess any appropriate next steps consistent with applicable law and administrative processes." This indicates that CMS is acknowledging the GAO’s findings but has not yet committed to halting the program.

The agency has also indicated steps to address concerns about the program’s implementation. Representative DelBene had previously raised specific questions about the payment structure for WISeR contractors with CMS Administrator Mehmet Oz. In a recent letter, Oz assured that the agency would be conducting audits of program participants to ensure their decisions align with existing Medicare coverage criteria. He also stated that vendors demonstrating a high rate of inaccuracy would face termination. However, the effectiveness and scope of these audits, as well as the transparency of the vendor payment formulas, remain subjects of ongoing scrutiny.

H3: The Broader Implications: AI in Healthcare and Medicare’s Future

The debate surrounding the WISeR program extends beyond a single pilot project; it touches upon fundamental questions about the role of artificial intelligence in healthcare and the future trajectory of Medicare. The integration of AI in healthcare holds immense promise for improving efficiency, enhancing diagnostic accuracy, and personalizing treatment plans. However, as the WISeR program illustrates, the implementation of these technologies must be approached with caution, prioritizing patient well-being and ethical considerations.

The concern that the WISeR program could serve as a "back door to privatizing Medicare" is a significant one. Medicare Advantage, the private insurance arm of Medicare, has already faced criticism for employing similar prior authorization tactics, often leading to patient access issues. If the WISeR model, which mirrors these practices, is scaled up within traditional Medicare, it could fundamentally alter the nature of this vital public program, potentially eroding the guaranteed access to care that has long been a hallmark of traditional Medicare.

The legislative resolutions introduced by Senate and House Democrats are designed to prevent this potential shift. For these resolutions to advance, they require a minimum of 30 signatures from senators to be brought out of committee and onto the Senate floor for a vote. A simple majority is then needed for passage. The question of whether these efforts will garner bipartisan support remains to be seen. However, if the resolutions successfully pass both the Senate and the House, the WISeR pilot program will be immediately rendered ineffective, marking a significant victory for those advocating for greater human oversight and patient-centric decision-making in Medicare. The outcome of this legislative push will likely set a precedent for how Congress approaches the integration of AI in federal healthcare programs moving forward.